Skip to main content
Brian W. Nolan

Brian W. Nolan

T +1 212 506 2517
F +1 212 849 5517
  • RSS Icon

IAM Patent 1000

Eighteen of the firm’s Intellectual Property partners are recognized in nine categories in the 2016 edition of the IAM Patent 1000—The World’s Leading Patent Professionals. The recognized lawyers are:

Brian W. Nolan is a member of the Intellectual Property group at Mayer Brown. Brian focuses his practice on intellectual property litigation, counseling, and due diligence in the areas of patent, trade secret, unfair competition, antitrust, trademark, counterfeit goods and copyright law. LMG Life Sciences recognized Brian as a “Life Sciences Star” and according to IAM 1000 “[Brian] Nolan is a key asset to the firm, given his wealth of pharmaceutical and biotechnology litigation expertise and ability to cross over seamlessly into other fields such as semiconductors and information technology.”

Brian has acted as lead trial counsel and appellate counsel on numerous matters covering all aspects of intellectual property protection. Brian has participated in several district court trials, ITC investigations, USPTO Inter Partes Review and appellate proceedings relating to a wide range of technologies, including monoclonal antibodies, pharmaceuticals, receptor pharmacology, medical devices, biotechnology, medical imaging technology, crystal growth, semiconductors, laser diodes, building products, data capture systems and computer storage systems. Brian has experience counseling clients concerning their biological products, including working to develop strategies to allow for introduction of new biologics to the marketplace and seeking to protect existing biologics from potential biosimilars competition. Additionally, Brian has experience litigating cases brought under the Hatch-Waxman statute and counseling innovator pharmaceutical companies regarding their patent portfolios and potential generic competition prior to patent expiry.

Brian regularly counsels investment companies concerning acquisitions in which the buyer’s valuation is driven by IP assets.  He works with public and private companies to develop patent strategies to enhance overall value.  Brian often advises on M&A, capital markets and other corporate transactions, including joint ventures, private equity, venture capital and hedge fund transactions.

Brian has acted as an adjunct professor of law at Fordham University School of Law, where he taught a course on patent litigation for many years. Brian speaks and writes on intellectual property issues at many events and in various publications. News organizations often seek Brian's views on current intellectual property issues.

The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.